List of Excipients in API acetaminophen, aspirin (nsaid) and caffeine
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing acetaminophen, aspirin (nsaid) and caffeine
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | EXCEDRIN | acetaminophen, aspirin (nsaid) and caffeine | 0067-2039 | BENZOIC ACID | |
| GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | EXCEDRIN | acetaminophen, aspirin (nsaid) and caffeine | 0067-2039 | CARNAUBA WAX | |
| GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | EXCEDRIN | acetaminophen, aspirin (nsaid) and caffeine | 0067-2039 | CELLULOSE, MICROCRYSTALLINE | |
| GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | EXCEDRIN | acetaminophen, aspirin (nsaid) and caffeine | 0067-2039 | FD&C BLUE NO. 1 | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for acetaminophen, aspirin (nsaid) and caffeine
Excipient focus: BENZOIC ACID
acetaminophen, aspirin (nsaid) and caffeine drug variants containing BENZOIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | acetaminophen, aspirin (nsaid) and caffeine | 0067-2039 |
| State of Florida DOH Central Pharmacy | acetaminophen, aspirin (nsaid) and caffeine | 53808-0835 |
| >Company | >Ingredient | >NDC |
acetaminophen, aspirin (nsaid) and caffeine drug variants not containing BENZOIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | acetaminophen, aspirin (nsaid) and caffeine | 0067-8201 |
| >Company | >Ingredient | >NDC |
Excipient focus: CARNAUBA WAX
acetaminophen, aspirin (nsaid) and caffeine drug variants containing CARNAUBA WAX
acetaminophen, aspirin (nsaid) and caffeine drug variants not containing CARNAUBA WAX
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
acetaminophen, aspirin (nsaid) and caffeine drug variants containing CELLULOSE, MICROCRYSTALLINE
acetaminophen, aspirin (nsaid) and caffeine drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
acetaminophen, aspirin (nsaid) and caffeine drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | acetaminophen, aspirin (nsaid) and caffeine | 0067-8201 |
| >Company | >Ingredient | >NDC |
acetaminophen, aspirin (nsaid) and caffeine drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | acetaminophen, aspirin (nsaid) and caffeine | 0067-2039 |
| State of Florida DOH Central Pharmacy | acetaminophen, aspirin (nsaid) and caffeine | 53808-0835 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
acetaminophen, aspirin (nsaid) and caffeine drug variants containing FD&C BLUE NO. 1
acetaminophen, aspirin (nsaid) and caffeine drug variants not containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
acetaminophen, aspirin (nsaid) and caffeine drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | acetaminophen, aspirin (nsaid) and caffeine | 0067-2039 |
| State of Florida DOH Central Pharmacy | acetaminophen, aspirin (nsaid) and caffeine | 53808-0835 |
| >Company | >Ingredient | >NDC |
acetaminophen, aspirin (nsaid) and caffeine drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | acetaminophen, aspirin (nsaid) and caffeine | 0067-8201 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
acetaminophen, aspirin (nsaid) and caffeine drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | acetaminophen, aspirin (nsaid) and caffeine | 0067-2039 |
| GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | acetaminophen, aspirin (nsaid) and caffeine | 0067-8201 |
| >Company | >Ingredient | >NDC |
acetaminophen, aspirin (nsaid) and caffeine drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| State of Florida DOH Central Pharmacy | acetaminophen, aspirin (nsaid) and caffeine | 53808-0835 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2208
acetaminophen, aspirin (nsaid) and caffeine drug variants containing HYPROMELLOSE 2208
| Company | Ingredient | NDC |
|---|---|---|
| State of Florida DOH Central Pharmacy | acetaminophen, aspirin (nsaid) and caffeine | 53808-0835 |
| >Company | >Ingredient | >NDC |
acetaminophen, aspirin (nsaid) and caffeine drug variants not containing HYPROMELLOSE 2208
| Company | Ingredient | NDC |
|---|---|---|
| GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | acetaminophen, aspirin (nsaid) and caffeine | 0067-2039 |
| GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | acetaminophen, aspirin (nsaid) and caffeine | 0067-8201 |
| >Company | >Ingredient | >NDC |
Excipient focus: LIGHT MINERAL OIL
acetaminophen, aspirin (nsaid) and caffeine drug variants containing LIGHT MINERAL OIL
| Company | Ingredient | NDC |
|---|---|---|
| GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | acetaminophen, aspirin (nsaid) and caffeine | 0067-2039 |
| State of Florida DOH Central Pharmacy | acetaminophen, aspirin (nsaid) and caffeine | 53808-0835 |
| >Company | >Ingredient | >NDC |
acetaminophen, aspirin (nsaid) and caffeine drug variants not containing LIGHT MINERAL OIL
| Company | Ingredient | NDC |
|---|---|---|
| GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | acetaminophen, aspirin (nsaid) and caffeine | 0067-8201 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 20
acetaminophen, aspirin (nsaid) and caffeine drug variants containing POLYSORBATE 20
| Company | Ingredient | NDC |
|---|---|---|
| GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | acetaminophen, aspirin (nsaid) and caffeine | 0067-2039 |
| State of Florida DOH Central Pharmacy | acetaminophen, aspirin (nsaid) and caffeine | 53808-0835 |
| >Company | >Ingredient | >NDC |
acetaminophen, aspirin (nsaid) and caffeine drug variants not containing POLYSORBATE 20
| Company | Ingredient | NDC |
|---|---|---|
| GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | acetaminophen, aspirin (nsaid) and caffeine | 0067-8201 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
acetaminophen, aspirin (nsaid) and caffeine drug variants containing POVIDONE
acetaminophen, aspirin (nsaid) and caffeine drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
acetaminophen, aspirin (nsaid) and caffeine drug variants containing PROPYLENE GLYCOL
acetaminophen, aspirin (nsaid) and caffeine drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SACCHARIN SODIUM
acetaminophen, aspirin (nsaid) and caffeine drug variants containing SACCHARIN SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | acetaminophen, aspirin (nsaid) and caffeine | 0067-8201 |
| >Company | >Ingredient | >NDC |
acetaminophen, aspirin (nsaid) and caffeine drug variants not containing SACCHARIN SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | acetaminophen, aspirin (nsaid) and caffeine | 0067-2039 |
| State of Florida DOH Central Pharmacy | acetaminophen, aspirin (nsaid) and caffeine | 53808-0835 |
| >Company | >Ingredient | >NDC |
Excipient focus: SORBITAN MONOLAURATE
acetaminophen, aspirin (nsaid) and caffeine drug variants containing SORBITAN MONOLAURATE
| Company | Ingredient | NDC |
|---|---|---|
| GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | acetaminophen, aspirin (nsaid) and caffeine | 0067-2039 |
| State of Florida DOH Central Pharmacy | acetaminophen, aspirin (nsaid) and caffeine | 53808-0835 |
| >Company | >Ingredient | >NDC |
acetaminophen, aspirin (nsaid) and caffeine drug variants not containing SORBITAN MONOLAURATE
| Company | Ingredient | NDC |
|---|---|---|
| GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | acetaminophen, aspirin (nsaid) and caffeine | 0067-8201 |
| >Company | >Ingredient | >NDC |
Excipient focus: STEARIC ACID
acetaminophen, aspirin (nsaid) and caffeine drug variants containing STEARIC ACID
acetaminophen, aspirin (nsaid) and caffeine drug variants not containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
acetaminophen, aspirin (nsaid) and caffeine drug variants containing TITANIUM DIOXIDE
acetaminophen, aspirin (nsaid) and caffeine drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
